We further evaluated the differential expression of these genes among different tumor grades and subtypes based on the IDH mutation status and 1p19q codeletion (subtype1: IDH mutant and 1p19q codeletion; subtype2: IDH mutant and 1p19q non-codeletion; IDH wild-type). This evidence concerns the gene IDH2 and neoplasm.